More about requirements, market review and general information about Russian market

When is it impossible to avoid conducting clinical trials with human subject on the territory of the Russian Federation?…

On 1 January 2017, the federal Law on Biomedical Cell Products (BMCP) came into force, regulating relations arising at all…

In accordance with Order N 885n, clinical trials of medical devices for in vitro diagnostics are conducted in laboratory…

All perfume and cosmetic product in consumer package falls under Custom Union Technical Regulation for cosmetics – CU TR…

Pharmaceuticals for human use registration

The main criterion for the possibility of conducting trials in the form of clinical evaluation is the presence of an interchangeable…

In addition to medical devices, biomedical cell products and medicines, many biologically active additives enter Russian…

Operational documentation for medical products

The healthcare expenses in Kazakhstan are equal to 3,7% of the GDP, which is lower than average in countries with the same…

In terms of money, the socially-economical performance of the Armenian healthcare system is one of the lowest.

Kyrgyzstan has launched a massive reform of its healthcare system and first of all, it is aimed at increasing first aid availability.